Cell and Tissue Preservation Market (By Type: Cell, Tissue; By Application: Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, Research & Development; By Product: Equipment, Software, Bio-preservation Media; By End User: Biobanks, Hospitals; By Cell Provider: CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cell and Tissue Preservation Market 

5.1. COVID-19 Landscape: Cell and Tissue Preservation Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cell and Tissue Preservation Market, By Type

8.1. Cell and Tissue Preservation Market, by Type, 2024-2033

8.1.1. Cell

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Tissue

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Cell and Tissue Preservation Market, By Application Type

9.1. Cell and Tissue Preservation Market, by Application Type, 2024-2033

9.1.1. Therapeutics

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Drug Discovery

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Gene therapy

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. IVF treatment

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Research & Development

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Cell therapy

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Cell and Tissue Preservation Market, By Product Type 

10.1. Cell and Tissue Preservation Market, by Product Type, 2024-2033

10.1.1. Equipment

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Software

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Bio-preservation Media

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Cell and Tissue Preservation Market, By End User Type

11.1. Cell and Tissue Preservation Market, by End User Type, 2024-2033

11.1.1. Biobanks

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Hospitals

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Cell and Tissue Preservation Market, By Cell Provider Type

12.1. Cell and Tissue Preservation Market, by Cell Provider, 2024-2033

12.1.1. CD34+

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. CD19+

12.1.2.1. Market Revenue and Forecast (2021-2033)

12.1.3. MSC

12.1.3.1. Market Revenue and Forecast (2021-2033)

12.1.4. iPSC

12.1.4.1. Market Revenue and Forecast (2021-2033)

12.1.5. hESC

12.1.5.1. Market Revenue and Forecast (2021-2033)

12.1.6. Tumor Cells

12.1.6.1. Market Revenue and Forecast (2021-2033)

12.1.7. Others

12.1.7.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Cell and Tissue Preservation  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.2. Market Revenue and Forecast, by Application (2021-2033)

13.1.3. Market Revenue and Forecast, by Product (2021-2033)

13.1.4. Market Revenue and Forecast, by End User (2021-2033)

13.1.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Product (2021-2033)

13.1.6.4. Market Revenue and Forecast, by End User (2021-2033)

13.1.7. Market Revenue and Forecast, by Cell Provider (2021-2033) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.1.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.1.8.3. Market Revenue and Forecast, by Product (2021-2033)

13.1.8.4. Market Revenue and Forecast, by End User (2021-2033)

13.1.8.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.3. Market Revenue and Forecast, by Product (2021-2033)

13.2.4. Market Revenue and Forecast, by End User (2021-2033) 

13.2.5. Market Revenue and Forecast, by Cell Provider (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Product (2021-2033)

13.2.7. Market Revenue and Forecast, by End User (2021-2033) 

13.2.8. Market Revenue and Forecast, by Cell Provider (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Product (2021-2033)

13.2.10. Market Revenue and Forecast, by End User (2021-2033)

13.2.11. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Product (2021-2033)

13.2.12.4. Market Revenue and Forecast, by End User (2021-2033)

13.2.13. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Type (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Application (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Product (2021-2033)

13.2.14.4. Market Revenue and Forecast, by End User (2021-2033)

13.2.15. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.3. Market Revenue and Forecast, by Product (2021-2033)

13.3.4. Market Revenue and Forecast, by End User (2021-2033)

13.3.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Product (2021-2033)

13.3.6.4. Market Revenue and Forecast, by End User (2021-2033)

13.3.7. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Product (2021-2033)

13.3.8.4. Market Revenue and Forecast, by End User (2021-2033)

13.3.9. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Product (2021-2033)

13.3.10.4. Market Revenue and Forecast, by End User (2021-2033)

13.3.10.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Type (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Product (2021-2033)

13.3.11.4. Market Revenue and Forecast, by End User (2021-2033)

13.3.11.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.3. Market Revenue and Forecast, by Product (2021-2033)

13.4.4. Market Revenue and Forecast, by End User (2021-2033)

13.4.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Product (2021-2033)

13.4.6.4. Market Revenue and Forecast, by End User (2021-2033)

13.4.7. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Product (2021-2033)

13.4.8.4. Market Revenue and Forecast, by End User (2021-2033)

13.4.9. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Product (2021-2033)

13.4.10.4. Market Revenue and Forecast, by End User (2021-2033)

13.4.10.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Type (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Product (2021-2033)

13.4.11.4. Market Revenue and Forecast, by End User (2021-2033)

13.4.11.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.2. Market Revenue and Forecast, by Application (2021-2033)

13.5.3. Market Revenue and Forecast, by Product (2021-2033)

13.5.4. Market Revenue and Forecast, by End User (2021-2033)

13.5.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Application (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Product (2021-2033)

13.5.6.4. Market Revenue and Forecast, by End User (2021-2033)

13.5.7. Market Revenue and Forecast, by Cell Provider (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Type (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Product (2021-2033)

13.5.8.4. Market Revenue and Forecast, by End User (2021-2033)

13.5.8.5. Market Revenue and Forecast, by Cell Provider (2021-2033)

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific, Inc.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Lonza

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. BD

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. MerckKGaA

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Cytiva

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Agilent Technologies, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Avantor, Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. FUJIFILM Irvine Scientific

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. BioLifeSolutions Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. AMSBIO

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

14.11. Princeton CryoTech

14.11.1. Company Overview

14.11.2. Product Offerings

14.11.3. Financial Performance

14.11.4. Recent Initiatives

14.12. STEMCELL Technologies Inc.

14.12.1. Company Overview

14.12.2. Product Offerings

14.12.3. Financial Performance

14.12.4. Recent Initiatives

14.13. LGC SeraCare

14.13.1. Company Overview

14.13.2. Product Offerings

14.13.3. Financial Performance

14.13.4. Recent Initiatives

14.14. Corning Incorporated

14.14.1. Company Overview

14.14.2. Product Offerings

14.14.3. Financial Performance

14.14.4. Recent Initiatives

14.15. CellGenix GmbH

14.15.1. Company Overview

14.15.2. Product Offerings

14.15.3. Financial Performance

14.15.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

PROCEED TO BUY :

   USD 4900
   USD 3800
   USD 2100
   USD 2100
   USD 7500

ASK FOR SAMPLE

No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample